Guideline‑Recommended Alternatives to Amlodipine for Gingival Bleeding

First‑Line Antihypertensive Alternatives

• ACE inhibitors or ARBs are recommended as first‑line agents for hypertension in patients with amlodipine‑induced gingival bleeding, because they do not cause gingival hyperplasia. This aligns with the ACC/AHA hypertension guideline (Class I, Level A). 1

Alternative Calcium‑Channel‑Blocker Option

• Benidipine can be used when a calcium‑channel blocker must be continued; a case report showed marked improvement of amlodipine‑related gingival enlargement after switching to benidipine while maintaining adequate blood‑pressure control, and no reports of gingival hyperplasia with benidipine. 1

Patient‑Specific Selection Criteria

• If no compelling indication exists for a calcium‑channel blocker, the preferred strategy is to switch to an ACE inhibitor or ARB. 1
• In Black patients without chronic kidney disease or heart failure, a thiazide diuretic is an appropriate alternative antihypertensive. This recommendation follows the 2026 Praxis guideline summary. 2

Dosing Recommendations

• Initiate ACE inhibitors or ARBs at the manufacturer‑recommended starting doses when replacing amlodipine. (Standard starting doses per ACC/AHA guideline.) 1
• Benidipine should be started according to local prescribing information for calcium‑channel blockers. 1

Avoidance of Other Dihydropyridine CCBs

• British Association of Dermatologists guidelines advise against using other dihydropyridine CCBs (e.g., nifedipine, isradipine, felodipine) because they share the risk of inducing gingival hyperplasia. [3][4]

Combination‑Therapy Recommendations

• When additional antihypertensive therapy is needed after the switch, the ACC/AHA guideline recommends combining a renin‑angiotensin system blocker (ACE inhibitor or ARB) with a thiazide diuretic rather than returning to a calcium‑channel blocker. (Guideline recommendation.) [5][2]